U
ARTX

UBS’s Arotech Corporation ARTX Stock Holding History

UBS’s Portfolio ARTX Stock Details ARTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Sell
200
-3,269
-94% -$12K ﹤0.01% 10218
2014
Q2 		$15K Buy
+3,469
New +$14.8K ﹤0.01% 8463
2014
Q1 		– Sell
-11,000
Closed -$38K – 11024
2013
Q4 		$38K Sell
11,000
-1,360
-11% -$3.04K ﹤0.01% 7329
2013
Q3 		$22K Buy
12,360
+7,360
+147% +$12.6K ﹤0.01% 7961
2013
Q2 		$8K Buy
+5,000
New +$6.32K ﹤0.01% 8899

Other funds holding ARTX

EWP
Edmunds White Partners Richmond, Virginia $69.2M AUM 56.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS's ARTX Position: Q3 2014 in Review

UBS reduced its Arotech Corporation (ARTX) stake by 94% in Q3 2014, selling an estimated $12K and leaving 200 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #10218.

UBS first reported a position in ARTX in Q2 2013 and has held it in 5 quarters since. The position peaked at $38K in Q4 2013. 34 funds tracked by Wall St. Rank hold ARTX as of Q3 2014.

  • UBS held 200 shares of Arotech Corporation worth $1K as of Q3 2014.
  • UBS sold 3,269 Arotech Corporation shares in Q3 2014, an estimated $12K.
  • Arotech Corporation made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10218 holding.
  • UBS first reported a position in Arotech Corporation in Q2 2013 and has held it in 5 quarters since.
  • UBS's Arotech Corporation position peaked at $38K in Q4 2013.
  • 34 funds tracked by Wall St. Rank held Arotech Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.